SMO and chronic myelogenous leukemia, BCR-ABL1 positive: In a murine CML model of study, deletion of SMO significantly reduced the CML CSCs, and conversely overexpression of SMO in a SMO-deficient mouse CML model dramatically enhanced CML CSCs 4-fold and significantly increased CML progression [52].